Ingredient or product comparison
GHK-Cu vs KLOW: Which Better for Recovery? | Real Peptides
Research from the Linus Pauling Institute confirmed that copper-binding peptides like GHK-Cu activate specific metalloproteinases. Enzymes that remodel the extracellular matrix during wound healing. At concentrations as low as 1 micromolar. KLOW (Lys-Pro-Val),
This source-based comparison does not add ratings or recommend a winner.
- Research from the Linus Pauling Institute confirmed that copper-binding peptides like GHK-Cu activate specific metalloproteinases. Enzymes that remodel the extracellular matrix during wound healing. At concentrations as low as 1 micromolar. KLOW (Lys-Pro-Val), by contrast, shows anti-inflammatory activity through a completely separate pathway: modulation of NF-κB signalling without any direct impact on collagen deposition or matrix metalloproteinase activity. Understanding this distinction matters because researchers often conflate 'tissue repair' with 'inflammation control'. But these are mechanistically distinct processes that require different peptide tools.
- Our team has worked with researchers comparing these peptides across tissue regeneration models for years. The gap between choosing the right peptide and wasting months on the wrong one comes down to understanding what each compound actually does at the receptor level. Not just what the marketing literature claims.
- What's the fundamental difference between GHK-Cu and KLOW in tissue repair research?
- GHK-Cu (glycyl-L-histidyl-L-lysine) functions as a copper-binding tripeptide that directly activates tissue remodeling enzymes, while KLOW (Lys-Pro-Val) acts as an anti-inflammatory tripeptide without metal-binding capacity or direct collagen synthesis activity. GHK-Cu's copper chelation enables it to stimulate fibroblast proliferation, increase collagen type I and III production, and enhance wound closure rates by 30–40% in controlled models. KLOW reduces pro-inflammatory cytokine expression (IL-6, TNF-α) but does not independently drive extracellular matrix synthesis. The choice depends entirely on whether the research objective prioritizes structural tissue regeneration versus inflammation modulation.
- Here's what most comparison guides miss: GHK-Cu's mechanism requires bioavailable copper to function. Without adequate copper ions in the microenvironment, the peptide's activity drops to near-baseline. KLOW's anti-inflammatory effect operates independently of metal cofactors, making it more consistent across varied tissue conditions but less impactful for structural repair. This article covers the specific receptor pathways each peptide activates, the measurable differences in tissue outcomes across wound healing and aging models, and the preparation protocols that determine whether either peptide performs as expected in research applications.